Arrowstreet Capital, Limited Partnership Voyager Therapeutics, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $108 Billion
- Q1 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 20,320 shares of VYGR stock, worth $160,731. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,320Holding current value
$160,731% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding VYGR
# of Institutions
134Shares Held
34.2MCall Options Held
35.3KPut Options Held
63K-
Armistice Capital, LLC New York, NY4.67MShares$37 Million0.59% of portfolio
-
Black Rock Inc. New York, NY4.4MShares$34.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$31 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$25.6 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$18.1 Million0.1% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $306M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...